Inventor · disambiguated record
James R. Mccarthy
Also filed as: GRIGORIADIS DIMITRI E · MCCARTHY JAMES R · MCCARTHY JAMES RAY · MCCARTHY JR JAMES R
78 granted patents·9 pending applications·773 citations·filing 1974–2015
99Inventor score
Files withMERRELL DOW PHARMA25NEUROCRINE BIOSCIENCES INC21MERRELL PHARMA INC9DOW CHEMICAL CO8MCCARTHY JAMES R7
Top patents by PatentIndex Score
87 records- 0197US5120764AInhibitors of lysyl oxidaseMERRELL DOW PHARMA·Filed 1988·Granted Jun 9, 1992·167 cites·2 claims
- 0291US5473104AProcess for the preparation of L-carnitineNEUROCRINE BIOSCIENCES INC·Filed 1994·Granted Dec 5, 1995·35 cites·19 claims
- 0390US6531475B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2000·Granted Mar 11, 2003·38 cites·44 claims
- 0484US6664261B2Pyrazolopyrimidines as CRF receptor antagonistsNEUROCRINE BIOSCIENCES INC·Filed 1997·Granted Dec 16, 2003·28 cites·14 claims
- 0583US5959109ACompounds and methods for increasing endogenous levels of corticotropin-releasing factorNEUROCRINE BIOSCIENCES INC·Filed 1996·Granted Sep 28, 1999·28 cites·18 claims
- 0682US7745438B23-(2-acylamino-1-hydroxyethyl)-morpholine derivatives and their use as bace inhibitorsLILLY CO ELI·Filed 2005·Granted Jun 29, 2010·8 cites·4 claims
- 0782US5977325A2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivativesMERRELL PHARMA INC·Filed 1998·Granted Nov 2, 1999·47 cites·13 claims
- 0881US7618978B2Amides as BACE inhibitorsLILLY CO ELI·Filed 2005·Granted Nov 17, 2009·6 cites·4 claims
- 0979US6610678B2CRF antagonistic quino-and quinazolinesFiled 2002·Granted Aug 26, 2003·11 cites·13 claims
- 1078US9206141B2Processes for preparing linezolidMCCARTHY JAMES R·Filed 2011·Granted Dec 8, 2015·3 cites·7 claims
- 1177US7074797B2Pyrazolopyrimidines as CRF receptor antagonistsNEUROCRINE BIOSCIENCES INC·Filed 2003·Granted Jul 11, 2006·6 cites·17 claims
- 1277US5378693A2'-halomethylidene cytidine, uridine and guanosine compounds and their pharmaceutical compositionsMERRELL DOW PHARMA·Filed 1993·Granted Jan 3, 1995·27 cites·14 claims
- 1376US6974808B2CRF receptor antagonists and methods relating theretoBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Dec 13, 2005·7 cites·5 claims
- 1476US6930120B2Oxazolyl-arylproplonic acid derivatives and their use as ppar agonistsLILLY CO ELI·Filed 2001·Granted Aug 16, 2005·10 cites·20 claims
- 1576US5011859ADi- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidaseMERRELL DOW PHARMA·Filed 1990·Granted Apr 30, 1991·14 cites·7 claims
- 1673US6723721B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Apr 20, 2004·5 cites·35 claims
- 1773US5064864ADi- and tetra-fluoro analogs of squalene as inhibitors of squalene epoxidaseMERRELL DOW PHARMA·Filed 1990·Granted Nov 12, 1991·12 cites·6 claims
- 1872US6747034B2CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2001·Granted Jun 8, 2004·5 cites·31 claims
- 1971US7846937B2Cyclopropanecarboxylate esters of acyclovirLILLY CO ELI·Filed 2006·Granted Dec 7, 2010·1 cites·7 claims
- 2071US7176224B2Oxazolyl-aryloxyacetic acid derivatives and their use as PPAR agonistsLILLY CO ELI·Filed 2001·Granted Feb 13, 2007·6 cites·40 claims
- 2170US6133276ACompounds and methods for increasing endogenous levels of corticotropin-releasing factorNEUROCRINE BIOSCIENCES INC·Filed 1998·Granted Oct 17, 2000·12 cites·65 claims
- 2270US5795905ACRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 1995·Granted Aug 18, 1998·31 cites·54 claims
- 2367US6211195B1CRF antagonistic thiophenopyridinesNEUROCRINE BIOSCIENCES INC·Filed 1998·Granted Apr 3, 2001·25 cites·16 claims
- 2463US3972931AN,N'-Disubstituted benzamidinesDOW CHEMICAL CO·Filed 1974·Granted Aug 3, 1976·13 cites·6 claims
- 2561US6514982B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 1999·Granted Feb 4, 2003·19 cites·32 claims
- 2661US5607925ATreatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosidesMERRELL PHARMA INC·Filed 1994·Granted Mar 4, 1997·12 cites·6 claims
- 2761US4810800ANovel imidazole dopamine beta hydroxylase inhibitorsMERRELL DOW PHARMA·Filed 1988·Granted Mar 7, 1989·5 cites·9 claims
- 2860US6352990B1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 1999·Granted Mar 5, 2002·14 cites·3 claims
- 2960US4745222ANovel aryloxycycloalkanolaminoalkylene aryl ketonesMERRELL DOW PHARMA·Filed 1984·Granted May 17, 1988·5 cites·17 claims
- 3060US2006270659A1Pyrazolopyrimidines as CRF receptor antagonistsNEUROCRINE BIOSCIENCES INC·Filed 2006·Application pending·0 cites
- 3159US5521162AAristeromycin analogues of 4',5'-didehydro-5'-fluoro-adenosine and methods of treating neoplastic and viral disease conditionsMERRELL PHARMA INC·Filed 1994·Granted May 28, 1996·6 cites·31 claims
- 3259US4743617AHeterocyclyl-2-propyn-1-aminesMERRELL DOW PHARMA·Filed 1987·Granted May 10, 1988·5 cites·18 claims
- 3359US4496725ASubstituted 1,2,3-triazino[4',5':4,5]-thieno[2,3-B]quinolin-4(3H)-onesDOW CHEMICAL CO·Filed 1983·Granted Jan 29, 1985·8 cites·2 claims
- 3459US4222857AApparatus for separating selected particulate materials from a mixture of solids and liquidsMCCARTHY JAMES R·Filed 1977·Granted Sep 16, 1980·14 cites·20 claims
- 3558US5616702A2-'-ethenylidene cytidine, uridine and guanosine derivativesMERRELL PHARMA INC·Filed 1994·Granted Apr 1, 1997·7 cites·13 claims
- 3658US4997924A5'-deoxy-4',5'-unsaturated-5'-substituted adenosinesMERRELL DOW PHARMA·Filed 1989·Granted Mar 5, 1991·8 cites·22 claims
- 3758US2004063659A1Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivativesMERRELL PHARMA INC·Filed 2003·Application pending·0 cites
- 3857US5760210AProcess for the preparation of ribonucleotide reductase inhibitorsMERRELL PHARMA INC·Filed 1996·Granted Jun 2, 1998·5 cites·1 claims
- 3957US5512678A5-(1-fluoro-vinyl)-1H-pyrimidine-2,4-dione derivatives useful as antineoplastic agentsMERRELL PHARMA INC·Filed 1994·Granted Apr 30, 1996·9 cites·8 claims
- 4057US5508393AProcess for the preparation of ribonucleotide reductase inhibitorsHOESCHST MARION ROUSSEL INC·Filed 1995·Granted Apr 16, 1996·7 cites·3 claims
- 4155US2004229879A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 4254US5589587AProcess for the preparation of ribonucleotide reductase inhibitorsMERRELL PHARMA INC·Filed 1995·Granted Dec 31, 1996·8 cites·3 claims
- 4354US2003109484A1Novel 2'-halomethylidene, 2'-ethenylidene and 2'ethynyl cytidine, uridine and guanosine derivativesFiled 2002·Application pending·0 cites
- 4453US2004157851A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 4553US2004121998A1CRF antagonistic quino- and quinazolinesNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
- 4652US4540484AMethod and apparatus for separating selected particulate materials from a mixture of liquids and solidsMCCARTHY JAMES R·Filed 1979·Granted Sep 10, 1985·10 cites·22 claims
- 4752US2004266799A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 4851US9751835B2Processes and intermediates for preparing indole pharmaceuticalsUNIV INDIANA RES & TECH CORP·Filed 2014·Granted Sep 5, 2017·0 cites·22 claims
- 4951US4996308ADerivatives with unsaturated substitutions for the 5'-hydroxymethyl groupMERRELL DOW PHARMA·Filed 1988·Granted Feb 26, 1991·5 cites·25 claims
- 5051US2004087589A1CRF receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 87 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →